Dr. Anne Beaven specializes in the treatment of all types of non-Hodgkin and Hodgkin lymphoma. She has a special interest in the management of patients with peripheral T cell lymphoma and cutaneous T cell lymphoma, for which she runs a multidisciplinary clinic in conjunction with dermatology.  She manages UNC based trials of CAR-T therapy for patients with T cell lymphoma.  On a national scale, she is a study Chair of the Alliance phase III study of Continuous vs intermittent maintenance therapy with Zanubrutinib as upfront treatment in older patients with mantle cell lymphoma.